Statistics at a Glance

At a Glance

Estimated New Cases in 2019 73,820

% of All New Cancer Cases 4.2%

Estimated Deaths in 2019 14,770

% of All Cancer Deaths 2.4%

Percent Surviving
5 Years

74.8% 2009-2015
Year New Cases - SEER 9 New Cases - SEER 13 Deaths - U.S. Percent Surviving 5 Years - SEER 9
Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend
1975 7.08 7.38 - - 3.61 3.54 52.31% 48.29%
1976 7.97 7.55 - - 3.61 3.58 51.94% 49.00%
1977 8.06 7.72 - - 3.68 3.62 46.79% 49.70%
1978 7.84 7.90 - - 3.69 3.67 54.06% 50.40%
1979 7.63 8.08 - - 3.63 3.71 50.44% 51.10%
1980 8.06 8.26 - - 3.68 3.75 54.74% 51.79%
1981 8.49 8.45 - - 3.73 3.79 47.72% 52.48%
1982 8.35 8.64 - - 3.85 3.84 49.81% 53.16%
1983 8.94 8.84 - - 3.85 3.88 53.03% 53.84%
1984 9.19 9.04 - - 3.90 3.93 55.34% 54.51%
1985 8.94 9.24 - - 3.96 3.97 55.39% 55.18%
1986 9.65 9.45 - - 4.05 4.02 53.65% 55.84%
1987 9.90 9.67 - - 4.14 4.07 56.86% 56.49%
1988 9.94 9.89 - - 4.03 4.11 57.32% 57.14%
1989 10.32 10.11 - - 4.16 4.16 56.65% 57.79%
1990 10.44 10.34 - - 4.19 4.21 60.03% 58.43%
1991 10.65 10.58 - - 4.30 4.26 60.52% 59.06%
1992 10.81 10.82 10.36 10.30 4.29 4.25 60.63% 59.69%
1993 10.76 11.06 10.35 10.44 4.16 4.25 61.26% 60.31%
1994 11.30 11.31 10.73 10.59 4.27 4.25 62.22% 60.92%
1995 11.12 11.26 10.69 10.74 4.34 4.24 61.64% 61.53%
1996 11.35 11.21 10.87 10.89 4.27 4.24 62.84% 62.13%
1997 10.97 11.16 10.79 11.04 4.27 4.24 61.93% 62.72%
1998 11.81 11.50 11.37 11.20 4.26 4.23 63.49% 63.31%
1999 11.45 11.86 11.28 11.35 4.06 4.23 62.75% 63.90%
2000 12.53 12.23 11.91 11.72 4.22 4.23 65.72% 64.47%
2001 12.61 12.61 12.19 12.09 4.27 4.22 66.68% 66.42%
2002 12.93 13.00 12.35 12.48 4.23 4.22 67.85% 68.29%
2003 13.57 13.41 13.03 12.88 4.20 4.18 69.20% 70.08%
2004 13.65 13.83 13.09 13.30 4.13 4.14 71.41% 71.80%
2005 14.07 14.26 13.50 13.73 4.13 4.10 74.78% 73.43%
2006 14.71 14.70 14.11 14.17 4.00 4.07 74.01% 74.99%
2007 15.62 15.16 14.99 14.62 4.02 4.03 75.35% 75.24%
2008 15.99 15.63 15.47 15.10 3.99 3.99 74.65% 75.49%
2009 15.38 15.62 15.10 15.09 3.93 3.95 76.38% 75.74%
2010 14.99 15.61 14.59 15.07 3.92 3.92 74.97% 75.98%
2011 15.57 15.60 14.92 15.06 3.94 3.88 73.40% 76.22%
2012 15.65 15.59 15.00 15.05 3.83 3.84 - 76.47%
2013 15.58 15.58 14.97 15.04 3.86 3.81 - 76.71%
2014 15.49 15.56 14.94 15.03 3.75 3.77 - 76.94%
2015 15.91 15.55 15.53 15.02 3.81 3.74 - 77.18%
2016 15.43 15.54 14.86 15.01 3.59 3.70 - 77.41%

Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.


Number of New Cases and Deaths per 100,000: The number of new cases of kidney and renal pelvis cancer was 16.1 per 100,000 men and women per year. The number of deaths was 3.8 per 100,000 men and women per year. These rates are age-adjusted and based on 2012-2016 cases and deaths.

Lifetime Risk of Developing Cancer: Approximately 1.7 percent of men and women will be diagnosed with kidney and renal pelvis cancer at some point during their lifetime, based on 2014-2016 data.

Prevalence of This Cancer: In 2016, there were an estimated 533,204 people living with kidney and renal pelvis cancer in the United States.

Did You Know? Video Series

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Kidney and Renal Pelvis Cancer?

Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

74.8%

Percent Surviving
5 Years

74.8%

Based on data from SEER 18 2009-2015. Gray figures represent those who have died from kidney and renal pelvis cancer. Green figures represent those who have survived 5 years or more.

Additional Information

Survival by Stage

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier kidney and renal pelvis cancer is caught, the better chance a person has of surviving five years after being diagnosed. For kidney and renal pelvis cancer, 65.1% are diagnosed at the local stage. The 5-year survival for localized kidney and renal pelvis cancer is 92.5%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Kidney and Renal Pelvis Cancer
Stage Percent of Cases 5-Year Relative Survival
Localized
Confined to Primary Site
65% 92.5%
Regional
Spread to Regional Lymph Nodes
17% 69.6%
Distant
Cancer Has Metastasized
16% 12.0%
Unknown
Unstaged
3% 41.9%

SEER 18 2009-2015, All Races, Both Sexes by SEER Summary Stage 2000

Additional Information

Number of New Cases and Deaths

How Common Is This Cancer?

Compared to other cancers, kidney and renal pelvis cancer is fairly common.

Rank Common Types of Cancer Estimated New
Cases 2019
Estimated
Deaths 2019
1. Breast Cancer (Female) 268,600 41,760
2. Lung and Bronchus Cancer 228,150 142,670
3. Prostate Cancer 174,650 31,620
4. Colorectal Cancer 145,600 51,020
5. Melanoma of the Skin 96,480 7,230
6. Bladder Cancer 80,470 17,670
7. Non-Hodgkin Lymphoma 74,200 19,970
8. Kidney and Renal Pelvis Cancer 73,820 14,770
9. Uterine Cancer 61,880 12,160
10. Leukemia 61,780 22,840

Kidney and renal pelvis cancer represents 4.2% of all new cancer cases in the U.S.

4.2%

In 2019, it is estimated that there will be 73,820 new cases of kidney and renal pelvis cancer and an estimated 14,770 people will die of this disease.

Who Gets This Cancer?

Kidney cancer is more common in men than women and among African Americans and American Indian and Alaska Native populations. The number of new cases of kidney and renal pelvis cancer was 16.1 per 100,000 men and women per year based on 2012-2016 cases.

Number of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Kidney and Renal Pelvis Cancer
Males
All Races 22.1
White 22.8
Black 24.3
Asian/Pacific Islander 12.0
American Indian/Alaska Native 21.2
Hispanic 20.8
Non-Hispanic 22.4
Females
All Races 10.9
White 11.3
Black 12.1
Asian/Pacific Islander 5.5
American Indian/Alaska Native 13.1
Hispanic 11.6
Non-Hispanic 10.8

SEER 21 2012-2016, Age-Adjusted

Percent of New Cases by Age Group: Kidney and Renal Pelvis Cancer
Age Range Percent of New Cases
<20 1.1%
20-34 1.9%
35-44 5.9%
45-54 15.4%
55-64 26.7%
65-74 27.7%
75-84 15.9%
>84 5.6%

Kidney and renal pelvis cancer is most frequently diagnosed among people aged 65-74.

Median Age
At Diagnosis

64

SEER 21 2012-2016, All Races, Both Sexes

Who Dies From This Cancer?

Kidney and renal pelvis cancer is the twelfth leading cause of cancer death in the United States. The number of deaths was 3.8 per 100,000 men and women per year based on 2012-2016 deaths.

Number of Deaths per 100,000 Persons by Race/Ethnicity & Sex: Kidney and Renal Pelvis Cancer
Males
All Races 5.5
White 5.7
Black 5.5
Asian/Pacific Islander 2.7
American Indian/Alaska Native 8.1
Hispanic 5.0
Non-Hispanic 5.6
Females
All Races 2.3
White 2.4
Black 2.3
Asian/Pacific Islander 1.1
American Indian/Alaska Native 3.8
Hispanic 2.3
Non-Hispanic 2.4

U.S. 2012-2016, Age-Adjusted

Percent of Deaths by Age Group: Kidney and Renal Pelvis Cancer
Age Range Percent of Deaths
<20 0.3%
20-34 0.6%
35-44 1.6%
45-54 7.9%
55-64 20.9%
65-74 27.8%
75-84 24.8%
>84 16.2%

The percent of kidney and renal pelvis cancer deaths is highest among people aged 65-74.

Median Age
At Death

71

U.S. 2012-2016, All Races, Both Sexes

Trends in Rates

Changes Over Time

Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, rates for new kidney and renal pelvis cancer cases have been stable over the last 10 years. Death rates have been falling on average 0.9% each year over 2007-2016. 5-year survival trends are shown below.

More About This Cancer

Cancer and the Kidney

Figure: Kidney and Adrenal Gland

Figure: The kidney (including the surrounding fibrous tissue and fat layer, the renal pelvis, and the ureter) and the adrenal gland, as well as a close-up view of the renal pelvis.

This cancer forms in tissues of the kidneys. Kidney cancer includes renal cell carcinoma (cancer that forms in the lining of very small tubes in the kidney that filter the blood and remove waste products) and renal pelvis carcinoma (cancer that forms in the center of the kidney where urine collects). It also includes Wilms tumor, which is a type of kidney cancer that usually develops in children under the age of 5.

Additional Information

More Information

Here are some resources for learning more about kidney cancer.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Kidney and Renal Pelvis Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/kidrp.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.